Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.40 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.39 |
| ▸ | KDM5C | P41229 | 1/20 | 0.36 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.35 |
| ▸ | IGF1R | P08069 | 1/20 | 0.35 |
| ▸ | HCAR3 | P49019 | 2/20 | 0.35 |
| ▸ | ALKBH1 | Q13686 | 2/20 | 0.34 |
| ▸ | HPGDS | O60760 | 1/20 | 0.34 |
| ▸ | ALKBH2 | Q6NS38 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | GFER | P55789 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2828291 | 0.84 | L3MBTL1 (0.68) | L3MBTL1EGLN1CYP4F2CYP4A11PLA2G4A | |
| SCHEMBL2826039 | 0.81 | L3MBTL1 (0.68) | L3MBTL1CYP4F2CYP4A11PLA2G4AALKBH1 | |
| SCHEMBL370482 | 0.75 | L3MBTL1 (0.62) | L3MBTL1EGLN1CYP4F2CYP4A11PLA2G4A | |
| SCHEMBL4240582 | 0.73 | L3MBTL1 (1.00) | L3MBTL1EGLN1CYP4F2CYP4A11PLA2G4A | |
| SCHEMBL18397011 | 0.72 | L3MBTL1 (0.50) | L3MBTL1ALDH1A1 | |
| SCHEMBL27175170 | 0.71 | L3MBTL1 (0.46) | L3MBTL1ALDH1A1LMNAMAPTCYP2C19 | |
| SCHEMBL23535650 | 0.71 | L3MBTL1 (0.50) | L3MBTL1IGF1RHCAR3ALDH1A1 | |
| SCHEMBL30590951 | 0.71 | L3MBTL1 (0.53) | L3MBTL1CYP4F2CYP4A11PLA2G4AALDH1A1 | |
| SCHEMBL18038382 | 0.71 | L3MBTL1 (0.71) | L3MBTL1EGLN1CYP4F2CYP4A11PLA2G4A | |
| SCHEMBL22183009 | 0.71 | L3MBTL1 (0.49) | L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120189489-A | Composition for treating neurodegenerative diseases, preparation method and application thereof | 深圳康普生物药业有限公司 | 2025-06-24 | — | — | CN | disclosed |
| EP-1773827-B1 | BENZOTHIAZOLE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2010-02-17 | — | — | EP | disclosed |
| US-7371749-B2 | Benzothiazole derivatives | HOFFMANN-LA ROCHE INC. (US) | 2008-05-13 | — | — | US | disclosed |
| EP-1773827-A1 | BENZOTHIAZOLE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2007-04-18 | — | — | EP | disclosed |
| US-20060019949-A1 | Benzothiazole derivatives | HOFFMANN-LA ROCHE INC. | 2006-01-26 | — | — | US | disclosed |
| WO-2006008041-A1 | BENZOTHIAZOLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2006-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060019949-A1 | Benzothiazole derivatives | CNR2, CNR1, CHRNA2 | L3MBTL1 1615/4885EGLN1 1007/4885CYP4F2 566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.